Diagnosis and management of esthesioneuroblastoma

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 11, Issue 2, 2003, Pages 112-118

  Bradley, Patrick J ^a   Jones, Nick S ^a   Robertson, Iain ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; VINCRISTINE;

BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; ESTHESIONEUROBLASTOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INCIDENCE; NECK METASTASIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOLOGY; REVIEW; TREATMENT OUTCOME; TUMOR DIAGNOSIS; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; HUMANS; MALE; NEOPLASM STAGING; NOSE NEOPLASMS; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; PROGNOSIS; RADIOTHERAPY; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037379372     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200304000-00009     Document Type: Review

References (58)

1. Dulguerov P, Allai AS, Calcaterra TC: Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2001, 2:683-690. This article is a classic and reviews all available papers through the MEDLINE database from 1990 to 2000. Worth obtaining and having available to all personnel who are involved in the management of esthesioneuroblastoma.
2. Berger L, Luc R, Richard D: 'esthesioneuroepitheliome olfactif. Bull Assoc Fr Etude Cancer 1924, 13:410-421.
3. Broich G, Pagliari A, Ottaviani F: Esthesioneuroblastoma: a general review of the disease published since the discovery of the tumour in 1924. Anticancer Res 1997, 17:2683-2706.
4. Rinaldo A, Ferlito A, Shaha AR, et al.: Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Otolaryngol 2002, 122:215-221. A review of the incidence and treatment of neck node metastases associated with esthesioneuroblastoma.
5. Dulguerov P, Calcaterra T: Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992, 102:843-849.
6. Carney ME, O'Reilly RC, Sholevar B, et al.: Expression of the human Achaetescute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma). J Neurooncol 1995, 26:35-43.
7. Margolis FL, Verhaagen J, Biffo S, et al.: Regulation of gene expression in the olfactory neuroepithelium: a neurogenic matrix. Prog Brain Res 1991, 89:97-122.
8. Guillemot F, Lo LC, Johnson JE, et al.: Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurones. Cell 1993, 75:463-475.
9. Benowitz LI, Routtenberg AA: A membrane phosphoprotein associated with neural development, axonal regeneration, phospholipid metabolism and synaptic plasticity. Trends Neurosci 1987, 10:527-532.
10. Margolis FL: A brain protein unique to the olfactory bulb. Proc Natl Acad Sci U S A 1972, 69:1221-1224.
11. Nibu K, Li G, Zhang X, et al.: Olfactory neuron-specific expression of NeuroD in mouse and human nasal mucosa. Cell Tissue Res 1999, 298:405-414.
12. Ball DW, Azzoli CG, Baylin SB, et al.: Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumours. Proc Natl Acad Sci U S A 1993, 90:5648-5652.
13. Sorensen PHB, Wu JK, Berean KW, et al.: Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumour related to the Ewing family of tumours: absence of EWS/FLI1 gene fusion and MIC2 expression. Am J Surg Pathol 1998, 22:391-398.
14. Kumar S, Perlman E, Pacck S, et al.: Absence of EWS/FLI1 fusion in olfactory neuroblastoma indicates these tumours do not belong to the Ewing's sarcoma family. Hum Pathol 1999, 30:1356-1360.
15. Mills SE, Gaffey MJ, Frierson HFJ: Tumors of the upper respiratory tract and ear. Case 26. Atlas of Tumour Pathology, series 3. Washington, DC: Armed Forces Institute of Pathology; 2000.
16. Kairemo KJA, Jekunen AP, Kestila MS, et al.: Imaging of olfactory neuroblastoma-an analysis of 17 cases. Auris Nasus Larynx 1998, 25:173-179.
17. Resto VA, Eisele DW, Forastiere A, et al.: Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 2000, 22:550-558.
18. Hirose T, Scheithauer BW, Lopes MBS, et al.: Olfactory neuroblastoma: an immunohistochemical, ultrasfructural, and flow cytometric study. Cancer 1995, 76:4-19.
19. Morita A, Ebersold MJ, Olsen KD, et al.: Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993, 32:706-715.
20. Cackett P, Weir C: Olfactory neuroblastoma-an unusual presentation. J Neuroophthalmol 2001, 21:90-91.
21. Arensen MA, Scheithauer BW, Freeman S: Cushing's syndrome secondary to olfactory neuroblastoma. Ultrastruct Pathol 1994, 18:61-68.
22. Osterman J, Calhoun A, Dunham M, et al.: Chronic syndrome of inappropriate antidiuretic hormone secretion and hypertension in a patient with olfactory neuroblastoma. Arch Intern Med 1986, 146:1731-1735.
23. Miyamoto RC, Gleich LL, Biddinger PW, et al.: Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: the impact of histological grading and clinical staging on survival and prognosis. Laryngoscope 2000, 110:1262-1265.
24. Musy PY, Reibel JF, Levine PA: Sinonasal undifferentiated carcinoma: the search for a better outcome. Laryngoscope 2002, 112:1450-1455.
25. Ogura JH, Schenek NL: Unusual nasal tumors: problems in diagnosis and treatment. Otolaryngol Clin North Am 1973, 6:813-837.
26. Hyams VJ, Olfactory neuroblastoma. In Tumors of the Upper Respiratory Tract and Ear. Edited by Hyams VJ, Batsakis JG, Michaels L. Washington DC: Armed Forces Institute of Pathology; 1988:240-248.
27. Foote RL, Morita A, Ebersold MJ, et al.: Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1993, 27:835-842.
28. Yousem DM, Oguz KK, Li C: Imaging of the olfactory system. Semin Ultrasound CT MR 2001, 22:456-472.
29. Pickuth P, Heywang-Kobrunner SH, Spielmann RP: Computed tomography and magnetic resonance imaging features of olfactory neuroblastoma: an analysis of 22 cases. Clin Otolaryngol 1999, 24:457-461.
30. Prado GLM, Itabashi Y, Noda H, et al.: Olfactory neuroblastoma visualised by technetium-99m-EDC SPECT. Radiat Med 2001, 19:267-270.
31. Kadish S, Goodman M, Wang CC: Olfactory neuroblastoma: a clinical analysis of 17 cases. Cancer 1976, 37:1571-1576.
32. Koka VN, Juliron M, Bourhis I, et al.: Aesthesioneuroblastoma. J Laryngol Otol 1998, 112:628-633.
33. Biller HF, Lawson W, Sachdev VP, et al.: Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope 1990, 100:1199-1201.
34. Polin R, Shehan JP, Chenelle AG, et al.: The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 1998, 42:1029-1037.
35. Eriksen JG, Bastholt L, Krogdahl AS, et al.: Esthesioneuroblastoma: what is the optimal treatment? Acta Oncol 2000, 39:231-235.
36. Chad KS, Kaplan C, Simpson JR, et al.: Esthesioneuroblastoma: the impact of treatment modality. Head Neck 2001, 23:749-757.
37. Shah JP: Surgery of the anterior skull base for malignant tumours. Acta Otorhinolaryngol Belg 1999, 53:191-194.
38. Girod D, Hanna E, Lawrence L: Esthesioneuroblastoma. Head Neck 2001, 23:500-505.
39. Lund VJ, Howard DJ, Wei WI, et al.: Craniofacial resection for tumours of the nasal cavity and paranasal sinuses-a 17 year experience. Head Neck 1998, 20:97-105.
40. Boyle JO, Shah KC, Shah JP: Craniofacial resection for malignant neoplasm of the skull base: an overview. J Surg Oncol 1998, 69:275-284.
41. Irish J, Dasgupta R, Freeman J, et al.: Outcome and analysis of the surgical management of esthesioneuroblastoma. J Otolaryngol 1997, 26:1-7.
42. Unger F, Walch C, Stammberger H, et al.: Olfactory neuroblastoma (esthesioneuroblastoma): report of six cases treated by a novel combination of endoscopic surgery and radiosurgery. Minim Invasive Neurosurg 2001, 44:79-84.
43. Walch C, Stammberger H, Anderhuber W, et al.: The minimally invasive approach to olfactory neuroblastoma: combined endoscopic and stereotactic treatment. Laryngoscope 2000, 110:635-640.
44. Casiano RR, Numa WA, Falaquez AM: Endoscopic resection of esthesioneuroblastoma. Am J Rhinol 2001, 15:271-279.
45. Slevin NJ, Irwin CJR, Banerjee SS, et al.: Olfactory neural tumors-the role of external beam radiotherapy. J Laryngol Otol 1996, 110:1012-1016.
46. Eich HT, Staar S, Micke O, et al.: Radiotherapy of esthesioneuroblastoma. Int J Radiat Oncol Biol Phys 2001, 49:155-160.
47. Zabel A, Thilmann C, Milker-Zabel S, et al.: The role of stereotactically guided conformal radiotherapy for local tumour control of esthesioneuroblastoma. Strahlenther Onkol 2002, 178:187-191.
48. Sheehan JM, Sheehan JP, Jane JA, et al.: Chemotherapy for esthesioneuroblastoma. Neurosurg Clin North Am 2000, 11:693-701.
49. McElroy EA, Buckner JC, Lewis JE: Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 1998, 42:1023-1028.
50. Shhari CM, Catalano PJ, Sen C, et al.: Central nervous system metastases from esthesioneuroma. Otolaryngol Head Neck Surg 1996, 114:808-812.
51. Chamberlain MC: Treatment of intracranial metastatic esthesioneuroblastoma. J Clin Oncol 2002, 20:357-358.
52. Davis RE, Weissler MC: Esthesioneuroblastoma and neck metastases. Head Neck 1992, 14:477-482.
53. Pickuth D, Heywang-Kobrunner SH: Imaging of recurrent esthesioneuroblastoma. Br J Radiol 1999, 72:1052-1057.
54. Miura K, Mineta H, Yokota N, et al.: Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemotherapy. Pathol Int 2001, 51:942-947.
55. Olsen KD, DeSanto LW: Olfactory neuroblastoma, biology and clinical behavior. Arch Otolaryngol 1983, 109:797-802.
56. Simon JH, Zhen W, McCulloch TM, et al.: Esthesioneuroblastoma: the University of Iowa experience 1978-1998. Laryngoscope 2001, 111:488-498.
57. Cusimano MD: Quality of life assessment in patients with lesions of the cranial base. Skull Base Surg 1999, 9:259-264.
58. Enepekides DJ, Donald PJ: Long-term outcomes of anterior skull base surgery. Curr Opin Otolaryngol Head Neck Surg 2000, 8:130-136.